|
Average of experiments I–II
|
|---|
|
Isolate code
|
Average disease index (%)*
|
|---|
|
K2L312
|
16.7 ± 0.86 a**
|
|
BY3L238
|
18.5 ± 0.51 a–c
|
|
HAL3T348
|
20.4 ± 0.93 a–b
|
|
AL1T1343
|
25.9 ± 0.51 a–d
|
|
A2L245
|
29.6 ± 0.40 a–d
|
|
Ö3L1315
|
29.6 ± 0.40 a–d
|
|
A3F1310
|
29.6 ± 0.65 a–d
|
|
Pss BAY3
|
37.0 ± 0.61 b–d
|
|
AL1T3324
|
37.0 ± 0.61 b–d
|
|
Psm 25B
|
37.0 ± 0.82 b–d
|
|
Ö3L2308
|
40.7 ± 0.35 cd
|
|
Psm 732
|
40.7 ± 0.75 b–d
|
|
BY5L316***
|
46.5 ± 0.43 d
|
- *The results are an average of the two trials. Four plantlets were evaluated in each trial for each treatment
- **According to Duncan’s multiple comparison test, the difference between the averages indicated by the same letters in the same column is insignificant according to P < 0.05
- ***The most virulent isolate, BY5L316, was selected to use in the next stage of the study
